Original Research

Factors Associated with Survival and Epidemiology of Gastrointestinal Neuroendocrine Tumors in the US Department of Veteran Affairs

Author and Disclosure Information

 

Introduction

Rectal carcinoid tumors are rare but the second most common carcinoid in the gastrointestinal tract. They are usually found incidentally during endoscopic or rectal examination. They do not often produce carcinoid syndrome like manifestations although they may manifest as rectal bleeding. Rectal carcinoid patients also have a higher morbidity for other cancers such as stomach, small intestine, or secondary lung cancer.

Methods

We retrospectively explored factors associated with survival in Veterans with rectal carcinoid tumors over a ten-year period from 2007-2017 using the National Veterans Affairs Cancer Cube Registry using specific histological ICD-03 coding. We identified 1110 cases of rectal carcinoid. Chi-squared tests were used for statistical analysis.

Results

Regarding age distribution in our cohort, there were 2.61% of patients ages 40-50 group, 14.0% in the 50-60 age group, 41.5% in the 60-70 age group, and 40.7% above ages 70. There was a higher proportion of rectal cancer in stage 1 compared to other stages (86.3%). The majority of diagnoses occur after age 50 (89.8%). A higher proportion of rectal carcinoid was identified in the 60-70 years category compared to <60 and >70 years old. In the general VA population, there are 80.2% White and 12.8% Black patients. We found a higher proportion of rectal carcinoid in Black patients (47.8%) over White patients (42.8%, p=0.02), which differs significantly from the racial makeup of the VA population (12.8% Black vs 80.3% White). Looking at survival time based on diagnosis, it is notable that 82.7% of individuals survive longer than 5 years when the diagnosis is made in ages 50-60 when compared to 68.7% when the diagnosis is made between ages 60-70 (p<0.001).

Conclusions

Our data is consistent with the SEER data in that the incidence and prevalence of rectal carcinoid are higher in Black patients compared to White patients. Further analysis into reasons for this racial disparity may prove beneficial to our understanding of this malignancy in the Veteran population. Further research is needed to determine whether diagnosis at a younger age offers a survival advantage in rectal carcinoid.

Recommended Reading

COVID booster may benefit active-treatment cancer patients
Federal Practitioner
Use and Toxicity of Checkpoint Inhibitors for Solid Tumor Treatment in a Veteran Population
Federal Practitioner
Better to binge drink than regularly tipple, suggests GI cancer study
Federal Practitioner
Pandemic-related drops in breast cancer screening hit hardest among medically underserved
Federal Practitioner
Although inconclusive, CV safety study of cancer therapy attracts attention
Federal Practitioner
NCCN recommends third COVID-19 dose for patients with cancer
Federal Practitioner
‘Dawn of a new era’ in the treatment of renal cell carcinoma
Federal Practitioner
Old saying about prostate cancer not true when it’s metastatic
Federal Practitioner
A Rapidly Progressive Thoracic Tumor
Federal Practitioner
Development of Debilitating Neuropathy After Two Cycles of Pembrolizumab
Federal Practitioner